Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Lung, Epithelial Cell Of Lung
DISEASE(S): Non-small Cell Lung Carcinoma
SUBMITTER: Jing Gao
LAB HEAD: Zhou Hu
PROVIDER: PXD032227 | Pride | 2022-10-13
REPOSITORIES: Pride
Items per page: 1 - 5 of 17 |
Theranostics 20220829 14
<b>Rationale:</b> The overall clinical response to FGFR inhibitor (FGFRi) is far from satisfactory in cancer patients stratified by FGFR aberration, the current biomarker in clinical practice. A novel biomarker to evaluate the therapeutic response to FGFRi in a non-invasive and dynamic manner is thus greatly desired. <b>Methods:</b> Six FGFR-aberrant cancer cell lines were used, including four FGFRi-sensitive ones (NCI-H1581, NCI-H716, RT112 and Hep3B) and two FGFRi-resistant ones (primary for N ...[more]